CRBP
Corbus Pharmaceuticals Holding
6.80$
+2.9%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | |
| – | 908.2% | 807.6% | 1,067.1% | 1,008.1% | 247.9% | 2.5% | 185.9% | – | – | – | – | |
| – | -808.2% | -707.6% | -967.1% | -908.1% | -147.9% | 100.0% | -85.9% | – | – | – | – | |
| – | 908.2% | 807.6% | 1,067.1% | 1,008.1% | 247.9% | 2,495.8% | 4,133.5% | – | – | – | – | |
| – | 557.3% | 338.0% | 367.3% | 268.7% | 65.4% | 723.4% | 2,316.6% | – | – | – | – | |
| – | 1,465.5% | 1,145.6% | 1,434.4% | 1,276.8% | 65.4% | 3,219.2% | 6,264.2% | – | – | – | – | |
| – | -1,365.5% | -1,045.6% | -1,334.4% | -1,176.8% | -213.3% | -3,119.2% | -6,350.1% | – | – | – | – | |
| – | 0.4% | 0.0% | 7.5% | 0.0% | 0.1% | 26.1% | 207.6% | – | – | – | – | |
| – | -1,365.1% | -1,046.3% | -1,328.6% | -1,154.5% | -197.7% | -2,826.1% | -5,176.4% | – | – | – | – | |
| – | 0.4% | 0.7% | -16.3% | 22.3% | -6.4% | 0.9% | -10.0% | – | – | – | – | |
| – | -1,365.1% | -1,046.3% | -1,328.6% | -1,154.5% | -197.7% | -2,826.1% | -5,166.4% | – | – | – | – | |
| – | -1,358.7% | -1,041.0% | -1,324.0% | -1,166.5% | -211.3% | -3,076.2% | -4,782.9% | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.